Wolverine Blend 10mg
LOT 1001
>99.50%
HPLC purity · meets spec
- Labeled
- 5mg / 5mg
- Measured
- 5.19mg / 5.99mg
- Identity
- BPC-157 · TB-500
- Tested
- Jul 17, 2026
3 assays passed · ISO/IEC 17025 accredited
View certificate
Tesamorelin | Peptide Vials
5mg
$68.00
Regular price
$102.00
Sale price
$68.00
Skip to product information
Tesamorelin | Peptide Vials
$68.00
Regular price
$102.00
Sale price
$68.00
Bundle & save
Price
$68.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
Tesamorelin
Mollecule Tesamorelin is manufactured for researchers seeking premium-quality peptide materials supported by verified laboratory testing. Every production lot is independently tested by accredited third-party laboratories, with Certificates of Analysis (COAs) available to confirm purity, identity, and manufacturing consistency.
Pack
5mg Peptide Vials: $68.00
10mg Peptide Vials: $119.00
20mg Peptide Vials: $220.00
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
ELI LILLY
TRIUMPH-4 Phase 3 Trial Results
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source -
PUBCHEM DATABASE
GLP-3 (RT) Compound Information
View Source -
CLINICALTRIALS.GOV
GLP-3 (RT) Clinical Trials Registry
View Source